Circulating FABP4 is a marker of metabolic and cardiovascular risk in SLE patients

Complement system and small HDL particles are associated with subclinical atherosclerosis in SLE patients

(2012) Sandra Parra et al.   ATHEROSCLEROSIS

Fatty acid-binding protein-4 plasma levels are associated to metabolic abnormalities and response to therapy in girls and young women with androgen excess

(2011) Iolanda Lázaro et al.   GYNECOLOGICAL ENDOCRINOLOGY

Inflammatory biomarkers and oxidative stress measurements in patients with systemic lupus erythematosus with or without metabolic syndrome

(2011) MAB Lozovoy et al.   LUPUS

Fatty Acid Binding Protein 4 Is Associated with Carotid Atherosclerosis and Outcome in Patients with Acute Ischemic Stroke

(2011) Sverre Holm et al.   PLoS One

Relation of Plasma Fatty Acid Binding Proteins 4 and 5 With the Metabolic Syndrome, Inflammation and Coronary Calcium in Patients With Type-2 Diabetes Mellitus

(2010) Roshanak Bagheri et al.   AMERICAN JOURNAL OF CARDIOLOGY

Fatty acid-binding protein 4 is associated with endothelial dysfunction in patients with type 2 diabetes

(2010) Gemma Aragonès et al.   ATHEROSCLEROSIS

Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Role of Proinflammatory Cytokines and Therapeutic Approaches

(2010) Chary López-Pedrera et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Expression of fatty acid-binding protein 4/aP2 is correlated with plaque instability in carotid atherosclerosis

(2010) H. E. Agardh et al.   JOURNAL OF INTERNAL MEDICINE

Nuclear Magnetic Resonance Lipoprotein Subclasses and the APOE Genotype Influence Carotid Atherosclerosis in Patients with Systemic Lupus Erythematosus

(2010) M. GONZALEZ et al.   JOURNAL OF RHEUMATOLOGY

Metabolic syndrome in patients with systemic lupus erythematosus: association with traditional risk factors for coronary heart disease and lupus characteristics

(2010) R. Telles et al.   LUPUS

Adipokines and Systemic Lupus Erythematosus: Relationship with Metabolic Syndrome and Cardiovascular Disease Risk Factors

(2009) M. VADACCA et al.   JOURNAL OF RHEUMATOLOGY

Metabolic Syndrome Is Associated with Increased Arterial Stiffness and Biomarkers of Subclinical Atherosclerosis in Patients with Systemic Lupus Erythematosus

(2009) J. M. SABIO et al.   JOURNAL OF RHEUMATOLOGY

Risk Factors for Development of Coronary Artery Disease in Women with Systemic Lupus Erythematosus

(2009) R. J. GOLDBERG et al.   JOURNAL OF RHEUMATOLOGY

Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis

(2009) CP Chung et al.   LUPUS

Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis

(2009) Ebru Erbay et al.   NATURE MEDICINE

Subclinical Atherosclerosis in Rheumatoid Arthritis and Systemic Lupus Erythematosus

(2008) Jane E. Salmon et al.   AMERICAN JOURNAL OF MEDICINE

Identification of a Lipokine, a Lipid Hormone Linking Adipose Tissue to Systemic Metabolism

(2008) Haiming Cao et al.   CELL

Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes

(2008) Anna Cabré et al.   JOURNAL OF LIPID RESEARCH

Use of Carotid Ultrasound to Identify Subclinical Vascular Disease and Evaluate Cardiovascular Disease Risk: A Consensus Statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force Endorsed by the Society for Vascular Medicine

(2008) James H. Stein et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

Metabolic syndrome in patients with systemic lupus erythematosus from Southern Spain

(2008) JM Sabio et al.   LUPUS

The fatty acid binding protein-4 (FABP4) is a strong biomarker of metabolic syndrome and lipodystrophy in HIV-infected patients

(2007) Blai Coll et al.   ATHEROSCLEROSIS

Systemic lupus erythematosus and “lupus dyslipoproteinemia”

(2007) Jozélio Freire de Carvalho et al.   AUTOIMMUNITY REVIEWS